Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Scienture Holdings, Inc. Director's Dealing 2021

Apr 15, 2021

35013_dirs_2021-04-15_11169f8d-eace-4bb9-8eff-c7576655115a.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: TRXADE GROUP, INC. (MEDS)
CIK: 0001382574
Period of Report: 2017-03-07

Reporting Person: Fell Donald G. (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2017-03-07 Common Stock S 500 $0.42 Acquired 774 Direct
2017-03-15 Common Stock S 500 $0.30 Acquired 1274 Direct
2017-03-30 Common Stock S 4 $0.25 Acquired 1278 Direct
2017-12-20 Common Stock S 800 $0.44 Acquired 2078 Direct
2018-01-24 Common Stock S 400 $0.37 Acquired 2478 Direct
2018-12-20 Common Stock S 3 $0.26 Acquired 2481 Direct
2019-02-01 Common Stock G 700 $0.00 Disposed 1781 Direct
2019-02-05 Common Stock S 2000 $0.55 Acquired 3781 Direct
2019-04-11 Common Stock G 700 $0.00 Disposed 3081 Direct
2019-06-11 Common Stock S 1000 $0.54 Acquired 4081 Direct
2019-07-02 Common Stock S 200 $0.62 Acquired 4281 Direct
2019-07-09 Common Stock G 1000 $0.00 Disposed 3281 Direct
2019-07-09 Common Stock G 1000 $0.00 Disposed 2281 Direct
2019-08-05 Common Stock S 1000 $0.55 Acquired 3281 Direct
2019-08-09 Common Stock G 1000 $0.00 Disposed 2281 Direct
2019-08-09 Common Stock G 500 $0.00 Disposed 1781 Direct
2019-08-09 Common Stock G 700 $0.00 Disposed 1081 Direct
2019-10-04 Common Stock G 500 $0.00 Disposed 581 Direct
2019-10-08 Common Stock S 1000 $1.00 Acquired 1581 Direct
2020-01-06 Common Stock G 200 $0.00 Disposed 1381 Direct
2020-01-06 Common Stock G 200 $0.00 Disposed 1181 Direct
2020-01-06 Common Stock G 200 $0.00 Disposed 981 Direct